These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 25634708)
21. Attention-deficit-hyperactivity disorder: an update. Dopheide JA; Pliszka SR Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419 [TBL] [Abstract][Full Text] [Related]
22. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009. Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998 [TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. Biederman J J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323 [TBL] [Abstract][Full Text] [Related]
24. Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder. Ayaz M; Ayaz AB; Soylu N; Yüksel S J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):442-7. PubMed ID: 25010598 [TBL] [Abstract][Full Text] [Related]
25. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. Faraone SV; Wilens TE J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377 [TBL] [Abstract][Full Text] [Related]
26. [Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)]. Käypä hoito suosituksen päivitystiivistelmä Duodecim; 2012; 128(5):539-40. PubMed ID: 22486070 [TBL] [Abstract][Full Text] [Related]
27. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. Upadhyaya HP J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378 [TBL] [Abstract][Full Text] [Related]
28. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study. van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369 [TBL] [Abstract][Full Text] [Related]
29. Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy. Schneider G; Banaschewski T; Feldman BL; Gustafsson PA; Murphy B; Reynolds M; Coghill DR; Spalding WM J Child Adolesc Psychopharmacol; 2019 May; 29(4):285-304. PubMed ID: 30942617 [No Abstract] [Full Text] [Related]
30. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Faraone SV; Glatt SJ J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220 [TBL] [Abstract][Full Text] [Related]
31. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy. Mohammadi M; Akhondzadeh S Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816 [TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapy of inattention and ADHD in adolescents. McBurnett K; Swetye M; Muhr H; Hendren RL Adolesc Med State Art Rev; 2013 Aug; 24(2):391-405, viii. PubMed ID: 24298754 [TBL] [Abstract][Full Text] [Related]
33. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622 [TBL] [Abstract][Full Text] [Related]
34. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication. Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Majnemer A Res Dev Disabil; 2012; 33(6):2080-7. PubMed ID: 22796639 [TBL] [Abstract][Full Text] [Related]
35. The evidence-based pharmacological treatment of paediatric ADHD. Vaughan BS; March JS; Kratochvil CJ Int J Neuropsychopharmacol; 2012 Feb; 15(1):27-39. PubMed ID: 21329553 [TBL] [Abstract][Full Text] [Related]
36. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges. Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546 [TBL] [Abstract][Full Text] [Related]
37. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]